A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder
Condition(s):Anxiety DisordersLast Updated:November 6, 2007Completed
Hide Studies Not Open or Pending
Condition(s):Anxiety DisordersLast Updated:November 6, 2007Completed
Condition(s):Anxiety DisorderLast Updated:October 18, 2007Completed
Condition(s):Anxiety DisordersLast Updated:November 6, 2007Completed
Condition(s):DyspepsiaLast Updated:September 24, 2007Completed
Condition(s):Depressive Disorder, MajorLast Updated:July 28, 2009Completed
Condition(s):Major Depressive DisorderLast Updated:August 19, 2009Completed
Condition(s):Breast Cancer; Hot Flashes; Sleep DisordersLast Updated:April 28, 2010Completed
Condition(s):Anxiety DisordersLast Updated:October 19, 2012Terminated
Condition(s):Major Depressive Disorder; Fibromyalgia; Diabetic Peripheral Neuropathic Pain; Generalized Anxiety DisorderLast Updated:October 23, 2023No longer available
Condition(s):DepressionLast Updated:May 21, 2007Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.